Back to search

Ireland· IE-PA-PA2299/018/001

Primene 10% Solution for Infusion

A aminosäuren product containing l-isoleucine + l-leucine + l-valine + l-lysine, registered in Ireland by Baxter Holding B.V.. The same ATC class is registered in 11 of our 19 countries.

ATC B05BA01

Checked against HPRA (Ireland) on

Informational only — not a medical device.

SOURCE REGISTER · IEHPRA (Ireland)normalisedPrimene 10% Solution for InfusionATCB05BA01REGISTER NO.IE-PA-PA2299/018/001PACKS LISTED1CHECKEDSeptember 28, 2026

Where it is registered

Aminosäuren is registered in 11 of 19 countries.

Countries holding a registration under ATC B05BA01 (aminosäuren), each read from that country’s own register.

  • This record: Ireland, from HPRA (Ireland)
  • 7 of them publish a price we can compare per daily dose

Aminosäuren · ATC B05BA01

11 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

HPRA (Ireland)
Active substance
L-isoleucine + L-leucine + L-valine + L-lysine
Manufacturer
Baxter Holding B.V.
Country
Ireland (IE)
ATC code
B05BA01
ATC class
Aminosäuren
Reimbursed
Not published by this register
Source register
HPRA (Ireland)
Last checked
September 28, 2026

Packs & prices · 1

  • ie_pa_number
    PA2299/018/001

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

4 interactions on record for aminosäuren.

Graded by severity as the source publishes them — 4 moderate. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Aminosäuren · interactions on record

4 records

  • 4 moderate

Most severe, free to view

  • AmfetamineN06BA01moderate
  • DexamfetamineN06BA02moderate
  • MetamfetamineN06BA03moderate
  • LisdexamfetamineN06BA12moderate
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Aminosäuren in 1 other country

What each register calls a product with the same active substance — salts and hydrates count as the same.

All aminosäuren products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of HPRA (Ireland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/f9964494-2314-465b-b6f2-1b556b2e4858
GET /v1/drugs/f9964494-2314-465b-b6f2-1b556b2e4858?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Solution for infusion",
  "routes": [
    "Not Currently Available"
  ],
  "source": "hpra",
  "atc_all": [
    "B05BA",
    "B05BA01"
  ],
  "strength": null,
  "pa_number": "PA2299/018/001",
  "substances": [
    "L-isoleucine",
    "L-leucine",
    "L-valine",
    "L-lysine",
    "L-methionine",
    "L-threonine",
    "L-tryptophan",
    "L-arginine",
    "L-histidine",
    "L-alanine",
    "L-aspartic acid",
    "Cysteine",
    "L-glutamic acid",
    "Glycine",
    "L-proline",
    "L-serine",
    "L-tyrosine",
    "Ornithine hydrochloride",
    "Taurine",
    "L-phenylalanine"
  ],
  "legal_basis": "Full application (Article 8(3) of Directive No 2001/83/EC)",
  "market_info": "Marketed",
  "authorised_at": "19/05/1995",
  "dispensing_status": "Product subject to prescription which may not be renewed (A)",
  "registration_status": "AU",
  "supply_legal_status": "Supply through pharmacies only",
  "interchangeable_code": null
}

See everything about aminosäuren.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.